USPTO serial 87679232
MAXIPIN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- JENKINS JR, CHARLES L
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MAXIPIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
WUHAN QR PHARMACEUTICALS CO., LTD.
WUHAN, HUBEI, CN
Other trademarks owned by WUHAN QR PHARMACEUTICALS CO., LTD.
WUHAN QR PHARMACEUTICALS CO., LTD.
WUHAN, HUBEI, CN
Other trademarks owned by WUHAN QR PHARMACEUTICALS CO., LTD.
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
WUHAN, HUBEI, CN
Other trademarks owned by WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
WUHAN, HUBEI, CN
Other trademarks owned by WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anticoagulants; Antifungal preparations; Cardiotonics; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of chronic heart failure; Pharmaceutical preparations for the treatment and prevention of heart failure; Pharmaceutical preparations for the treatment and prevention of idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment and prevention of non-alcoholic steatohepatitis; Pharmaceutical preparations for the treatment and prevention of thrombosis; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical products for treating respiratory diseases and asthma | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by WUHAN QR PHARMACEUTICALS CO., LTD.
- Other trademarks owned by WUHAN QR PHARMACEUTICALS CO., LTD.
- Other trademarks owned by WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
- Other trademarks owned by WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
- Other trademarks in Class 005
- Similar marks named MAXIPIN
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 23, 2019 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 23, 2019 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 7, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 3, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 3, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 3, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 13, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 11, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 11, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 11, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 22, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 27, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 27, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 7, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 21, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 21, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 20, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 13, 2017 | NWAP | NEW APPLICATION ENTERED | — |